Kasey L Couts

7PUBLICATIONS
67CO-AUTHORS
Molecular targetsTumour immunologyPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 13, 2026
Decitabine reverses innate immune gene suppression in rare melanomas.

|Jan 28, 2026
Human Alpha-1 Antitrypsin Suppresses Melanoma Growth by Promoting Tumor Differentiation and CD8+ T-Cell-Mediated Immunity.

Takeshi Yamauchi, Yuchun Luo, Dinoop Ravindran Menon

|Jan 27, 2026
Profiling Serum Oxylipin Metabolites Across Melanoma Subtypes and Immunotherapy Responders.

Alexander C Goodman, Kylie M Michel, Morgan L MacBeth

|Sep 05, 2025
Decitabine reverses innate immune gene suppression in rare melanomas.

Morgan L MacBeth, Stacey M Bagby, Jessica S W Borgers

|Jul 13, 2024
Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling.

Jacqueline A Turner, Robert J Van Gulick, William A Robinson

|Nov 15, 2022
Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma.

Richard P Tobin, Dasha T Cogswell, Victoria M Cates

Pageof 2

Frequent Collaborators

3 joint publications

William A Robinson

2 joint publications

Martin D McCarter

2 joint publications

Morgan L MacBeth

2 joint publications

Jessica S W Borgers